PuraPharm Corporation Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was HKD 601.815 million compared to HKD 695.879 million a year ago. Net income was HKD 31.710 million compared to net loss of HKD 227.258 million a year ago. Basic earnings per share from continuing operations was HKD 0.0855 compared to basic loss per share from continuing operations of HKD 0.8716 a year ago. Diluted earnings per share from continuing operations was HKD 0.0854 compared to diluted loss per share from continuing operations of HKD 0.8716 a year ago.